Enlivex Therapeutics is focused on harnessing macrophages to treat inflammatory diseases through its cell therapy platform Allocetra™, which is designed for various therapeutic applications.

Enlivex Therapeutics

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Enlivex Therapeutics Ltd.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 11, 2024 9:10 AM	784f15ab
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 9:10 AM	d7f2dc9b
crunchbase trigger	general	Nov 27, 2024 12:50 PM	2ddb27df
crunchbase profile	general
li profile	general	Nov 11, 2024 9:10 AM	080e77d7
translate crunchbase fundingrounds	general
peers	general	Nov 11, 2024 9:10 AM	e9e06e43
news basic	general	Nov 11, 2024 9:10 AM	e794c087
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ENLIVEX

Enlivex Therapeutics

Last Close

0.84

22/11 21:00

Market Cap

29.22M

Beta: -

Volume Today

221.59K

Avg: -